Reports

• Business And Financial

Orchestra BioMed Reports Third Quarter 2024 Financial

2 years ago admin

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”),...

• Business And Financial

AMSC Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Business Outlook

2 years ago admin

Financial Highlights: Reported Second Quarter Net Income of Nearly $5 Million Generated Nearly $13 Million of Operating Cash Flow During...

• Business And Financial

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

2 years ago admin

Agios Pharmaceuticals reported Q3 2024 financial results and business highlights. The company achieved $9.0 million...

• Business And Financial

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

2 years ago admin

—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over...

• Business And Financial

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results

2 years ago admin

Nanobiotix (NASDAQ: NBTX) provided a business update and reported half-year 2024 financial results. Key highlights...

• Business And Financial

WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth

2 years ago admin

Revenue surged by 67.6% YoY to RMB 1,665 million Gross profit surged by 133.4% to RMB 535 million, with a...